EarningsQ4 2023 Earnings Report

COSCIENS Biopharma (ET80) Q4 2023 Earnings Report

0 Followers

DE:ET80 Q4 2023 EPS Results

Actual EPS-€4.00

Consensus EPS-€3.34

Beat/MissMissed by -€0.65

One Year Ago EPS-€8.82

Actual Revenue€102.48K

Expected Revenue€0.00

Beat/MissBeat by +€102.48K

YoY Revenue Growth-95.12%

QuarterQ4 2023

Date03/27/2024

TimeBefore Open

Conference CallWednesday, March 27, 2024

DE:ET80 Upcoming Earnings

COSCIENS Biopharma's next earnings date is estimated for November 17, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 17, 2026	2026 (Q3)	- / -	-1.471	―
Aug 11, 2026	2026 (Q2)	- / -0.17	-2.198	92.44% (+2.03)
May 12, 2026	2026 (Q1)	- / -0.44	-3.111	85.97% (+2.67)
Apr 15, 2026	2025 (Q4)	- / -1.78	-5.602	68.15% (+3.82)
Nov 11, 2025	2025 (Q3)	- / -1.47	-3.451	57.39% (+1.98)
Aug 14, 2025	2025 (Q2)	- / -2.20	-1.194	-84.06% (-1.00)
May 13, 2025	2025 (Q1)	- / -1.00	-12.255	91.84% (+11.26)
Apr 09, 2025	2024 (Q4)	- / -3.11	-8.843	64.82% (+5.73)
Nov 12, 2024	2024 (Q3)	- / -4.78	-8.79	45.59% (+4.01)
Aug 08, 2024	2024 (Q2)	- / -	-0.323	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed